Tysabri

Medicinal product

(Invented) name

Tysabri

Active substance (s)

Natalizumabas

Strength

300 mg

Pharmaceutical form

koncentratas infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L04AG03, Natalizumab

Marketing authorisation holder

UAB Lex ano, Lietuva

Date of authorisation

2014-01-28

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

CR-Lygiagretus platinimas

Qualitative and quantitative composition

Viename flakone yra	15 ml
Natalizumabas	300 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
61336	75654	1075654	flakonas	15 ml (20 mg/ml) N1		Receptinis	EU/1/06/346/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2014-01-28	Registruotas